- Home
- NOG vs VCEL Comparison
NOG vs VCEL Comparison
Compare NOG & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOG | VCEL |
|---|---|---|
| Founded | 2006 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NOG | VCEL |
|---|---|---|
| Price | $25.83 | $39.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $31.14 | ★ $57.75 |
| AVG Volume (30 Days) | ★ 2.2M | 429.7K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.44% | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,475,723,000.00 | $276,259,000.00 |
| Revenue This Year | $14.07 | $19.40 |
| Revenue Next Year | $4.24 | $18.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 11.23 | ★ 16.45 |
| 52 Week Low | $17.18 | $28.95 |
| 52 Week High | $31.17 | $49.32 |
Technical Indicators
Market Signals| Indicator | NOG | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 32.47 |
| Support Level | $25.43 | $35.45 |
| Resistance Level | $28.81 | $40.17 |
| Average True Range (ATR) | 0.76 | 1.35 |
| MACD | -0.21 | -0.27 |
| Stochastic Oscillator | 19.49 | 8.67 |
Price Performance
Historical ComparisonAbout NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.